# Patient-derived Organoids Drug Screen in Pancreatic Cancer

> **NCT05351983** · NA · COMPLETED · sponsor: **Prof. Dr. med. Dres. h.c. Jan Schmidt, MME** · enrollment: 60 (actual)

## Conditions studied

- Pancreas Cancer
- Pancreas Neoplasm
- Pancreas Adenocarcinoma
- Pancreatic Cancer
- Pancreatic Neoplasms
- Pancreatic Adenocarcinoma

## Interventions

- **PROCEDURE:** Surgical biopsy of tumoral tissue for organoid generation

## Key facts

- **NCT ID:** NCT05351983
- **Lead sponsor:** Prof. Dr. med. Dres. h.c. Jan Schmidt, MME
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-22
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05351983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05351983, "Patient-derived Organoids Drug Screen in Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05351983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*